NOVONESIS

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NOVONESIS and other ETFs, options, and stocks.

About NVZMY

Novonesis (Novozymes A/S) engages in the era of biosolutions. It innovate and develop transformative biosolutions that improve the way the world produces, consumes, and lives. 

CEO
Ester Baiget
CEOEster Baiget
Employees
11,641
Employees11,641
Headquarters
Lyngby, North Denmark
HeadquartersLyngby, North Denmark
Founded
Founded
Employees
11,641
Employees11,641

NVZMY Key Statistics

Market cap
29.77B
Market cap29.77B
Price-Earnings ratio
43.87
Price-Earnings ratio43.87
Dividend yield
0.91%
Dividend yield0.91%
Average volume
42.30K
Average volume42.30K
High today
$63.76
High today$63.76
Low today
$62.61
Low today$62.61
Open price
$63.62
Open price$63.62
Volume
40.12K
Volume40.12K
52 Week high
$73.18
52 Week high$73.18
52 Week low
$49.90
52 Week low$49.90

NVZMY News

TipRanks 3d
Novonesis upgraded to Neutral from Underperform at BNP Paribas

BNP Paribas upgraded Novonesis (NVZMY) to Neutral from Underperform with a price target of DKK 415, up from DKK 362. The firm cites valuation following the stoc...

Analyst ratings

84%

of 19 ratings
Buy
84.2%
Hold
15.8%
Sell
0%

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.